EcoDrugPlus

Lysyl Oxidase-Like 2b

Ensembl ID : ENSTNIG00000018860
Gene Symbol: LOXL2B
2 Cross references
213 Possible Orthologues:

Macrophage Migration Inhibitory Factor

Ensembl ID : ENSTNIG00000013115
Gene Symbol: MIF
2 Cross references
229 Possible Orthologues:

Macrophage Stimulating 1 Receptor

Ensembl ID : ENSTNIG00000007333
Gene Symbol: MST1R
2 Cross references
193 Possible Orthologues:

Matrix Metallopeptidase 13a

Ensembl ID : ENSTNIG00000003287
Gene Symbol: MMP13A
2 Cross references
306 Possible Orthologues:

Matrix Metallopeptidase 14

Ensembl ID : ENSTNIG00000001898
Gene Symbol: MMP14
2 Cross references
197 Possible Orthologues:

Matrix Metallopeptidase 14a (Membrane-Inserted)

Ensembl ID : ENSTNIG00000013838
Gene Symbol: MMP14A
2 Cross references
197 Possible Orthologues:

Matrix Metallopeptidase 14b (Membrane-Inserted)

Ensembl ID : ENSTNIG00000007935
Gene Symbol: MMP14B
2 Cross references
196 Possible Orthologues:

Matrix Metallopeptidase 2

Ensembl ID : ENSTNIG00000006605
Gene Symbol: MMP2
2 Cross references
209 Possible Orthologues:

Matrix Metallopeptidase 9

Ensembl ID : ENSTNIG00000015124
Gene Symbol: MMP9
2 Cross references
215 Possible Orthologues:

Mechanistic Target Of Rapamycin Kinase

Ensembl ID : ENSTNIG00000010886
Gene Symbol: MTOR
2 Cross references
18 Possible Orthologues:

Mechanistic Target Of Rapamycin Kinase

Ensembl ID : ENSTNIG00000005717
Gene Symbol: MTOR
2 Cross references
63 Possible Orthologues:

Melanocortin 1 Receptor

Ensembl ID : ENSTNIG00000009288
Gene Symbol: MC1R
3 Cross references
159 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).